ORPRO THERAPEUTICS INC.
CEO: Peter Heifetz.
No. of local employees: Two full-time, supplemented by consultants and advisers.
Headquarters: San Diego.
Year founded: 2011.
Company description: Preclinical stage biopharmaceutical company developing recombinant thioredoxin for the treatment of cystic fibrosis and other obstructive pulmonary diseases.
Key factors for success: Backing by National Institutes of Health. Has assembled ‘world-class’ team of experts to advise on research, development, manufacturing and financing.
A monetary ripple in the funding waters could bring a wave of change to OrPro Therapeutics Inc...